FIELD: chemistry.
SUBSTANCE: invention relates to a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof. In the formula (1) R1 is C1-6 alkyl group; R2 and R3 are the same or different from each other and each represents a hydrogen atom or a C1-6 alkyl group; X2, X3 and X4 are the same or different from each other and each represents a hydrogen atom or a halogen atom; and X5 represents a hydrogen atom or -P(=O)(OH)2. Invention also relates to compounds selected from the group, to individual compounds and to a pharmaceutical composition.
.
EFFECT: new compounds of formula (1) having the properties of a Wnt signaling inhibitor have been obtained.
17 cl, 3 dwg, 6 tbl, 29 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CRYSTAL (6S,9AS)-N-BENZYL-8-({6-[3-(4-ETHYLPIPERAZIN-1-YL)AZETIDIN-1-YL]PYRIDIN-2-YL}METHYL)-6-(2-FLUORINE-4-HYDROXYBENZYL)-4,7-DIOXO-2-(PROP-2-EN-1-YL)HEXAHYDRO-2H-PYRAZINO[2,1-C][1,2,4]TRIAZINE-1(6H)-CARBOXAMIDE | 2016 |
|
RU2723551C2 |
| ANTICANCER AGENT | 2016 |
|
RU2729936C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING A TUMOUR | 2018 |
|
RU2750539C2 |
| ALPHA-SPIRAL MIMETICS AND METHODS ASSOCIATED WITH THEM | 2009 |
|
RU2512538C2 |
| NEW COMPOUNDS MIMETICS AND USING THEM | 2008 |
|
RU2457210C2 |
| ANELLATED 9-HYDROXY-1,8-DIOXO-1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDES - INTEGRASE INHIBITORS, METHODS FOR PREPARING AND USING THEREOF | 2019 |
|
RU2717101C1 |
| SUBSTITUTED HETEROCYCLIC FUSED CYCLIC COMPOUND, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2020 |
|
RU2815814C1 |
| JAK INHIBITOR COMPOUND AND USE THEREOF | 2020 |
|
RU2820445C2 |
| 8-METHYL-1-PHENYLIMIDAZO[1,5-a]PYRAZINE COMPOUNDS | 2011 |
|
RU2560162C2 |
| FGFR AND ITS MUTATION INHIBITOR, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2811207C1 |
